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Conclusions ETs of the monomeric ET-rich extract 
are more prone to intestinal breakdown than those of the 
dimeric ET-rich extract, and absorption of their metabolites 
can be increased by dietary FOS; however, together, they 
evoke strong antibacterial activity.
Keywords Bifidobacteria · Fructans · Hydrolysable 
tannins · Lactic acid bacteria · Nasutins · Urolithins
Introduction
Ellagitannins (ETs) are a heterogeneous class of plant poly-
phenols with a complex chemical structure, in which one 
or more groups of hexahydroxydiyphenic acid, an ellagic 
acid precursor, are linked to a central glycosidic unit, usu-
ally glucose [1, 2]. These diverse monomeric forms of ETs 
often have gallic acid in their structures and can be bound 
together to form oligomers and polymers. Despite the high 
molecular weight of ETs and thus a limited bio-availability, 
numerous biological activities have been ascribed to them, 
such as antioxidant, anti-inflammatory and anticancer prop-
erties [2]. These effects are due to the gut microbiota that 
can convert ETs and ellagic acid to more bio-available 
metabolites, mainly urolithins, which have free and con-
jugated forms that are in both the blood and urine [3–7]. 
However, it is noteworthy that the metabolism and bio-
activity of ETs should not be overgeneralized because of 
their diverse chemical structure, which largely depends on 
the plant source. For example, a recent study performed by 
our group showed that the ingestion of defatted raspberry 
seeds, compared to defatted strawberry seeds, resulted in a 
lower concentration of their metabolites in the distal intes-
tine, although they contained almost twice as much ETs 
[8].
Abstract 
Purpose We investigated the effects of dietary supple-
mentation with strawberry extracts rich in ETs and fructo-
oligosaccharides (FOS) on the intestinal microbiota and the 
formation of bacterial metabolites in the distal intestine, as 
well as the absorption of ET metabolites and antioxidant 
status in rats.
Methods Rats were allocated into six groups of eight 
animals each and fed for 4 weeks with a control diet 
(group C), a control diet supplemented with FOS (group 
C + FOS) or modifications of these diets, in which a mon-
omeric or dimeric ET-rich extract was added (groups ME 
and ME + FOS or DE and DE + FOS, respectively).
Results The extract addition, the FOS addition and their 
interaction significantly affected the total and selected bac-
terial counts in the caecal digesta (all P < 0.005). The total 
bacterial count was the highest in group C + FOS, lower in 
group DE and the lowest in group ME + FOS (10.6, 10.3 
and 8.52 log cells/g, respectively; P ≤ 0.05). The total cae-
cal content of ET metabolites was higher in the ME and 
ME + FOS group than in the DE and DE + FOS group, 
respectively (67.8 and 89.5 vs. 13.0 and 18.0 µg/g, respec-
tively; P < 0.001). The total plasma concentration of ET 
metabolites was higher in the ME + FOS and DE + FOS 
group than in the ME group (248 and 281 vs. 8.13 ng/mL, 
respectively; P < 0.001).
 * Adam Jurgon´ski 
 a.jurgonski@pan.olsztyn.pl
1 Division of Food Science, Institute of Animal Reproduction 
and Food Research, Polish Academy of Sciences, Tuwima 
10, 10-748 Olsztyn, Poland
2 Institute of Food Technology and Analysis, Lódz´ University 
of Technology, Stefanowskiego 4/10, 90-924 Lodz, Poland
854 Eur J Nutr (2017) 56:853–864
1 3
Strawberries are abundant in antioxidant compounds, 
mainly vitamin C, anthocyanins and ETs, which together 
determine their high in vitro antioxidant capacity [9]. ETs 
are present in strawberries as monomers and dimers with 
dimeric agrimoniin found as a predominant ET both in 
the whole fruits and especially in their pomace, which is a 
by-product of juice manufacturing [10–13]. Many experi-
ments have shown that strawberry consumption can exert 
a significant antioxidant effect on the organism; however, 
a possible contribution of ETs to this action has not been 
recognized thus far [9, 13].
Additional dietary components of plant origin interact-
ing with the gut microbiota are prebiotic fructo-oligosac-
charides (FOS), which cannot be digested by pancreatic 
enzymes and serve as an energy substrate for specific intes-
tinal bacteria. FOS become more and more popular dietary 
ingredient that occur naturally in many vegetables, as well 
as some cereals and fruits. FOS ingestion improves the 
overall gastrointestinal condition and leads to the forma-
tion of preferable intestinal microbiota, among other effects 
[14]. A recent study performed in our laboratory suggested 
that dietary FOS can increase the content of nasutin-A, a 
metabolite of strawberry ETs, in the intestinal digesta of 
rats. Thus, some beneficial changes in the gut microbiota 
following simultaneous ingestion of those dietary compo-
nents as well as a possible increase in ET bio-availability 
have been suggested [15].
We hypothesized that various classes of strawberry ETs 
are disparately metabolized in the distal intestine and that 
the process is modulated by dietary FOS, which in turn can 
affect the absorption of ET metabolites and the antioxidant 
status of the organism. Thus, a nutritional experiment on 
rats was designed to determine the effects of dietary sup-
plementation with FOS and strawberry extracts, containing 
various proportions of monomeric and dimeric ETs, on the 
occurrence of selected bacterial populations and the metab-
olite formation in the distal intestine. Moreover, the effects 
of the dietary treatments on the plasma concentration of ET 
metabolites, the plasma antioxidant capacity and the degree 
of lipid peroxidation in selected tissues (liver, heart and 
kidney) were investigated.
Methods
Preparation of strawberry ET‑rich extracts  
and their analysis
The extracts were obtained from strawberry fruit pomace, a 
by-product of the manufacture of concentrated strawberry 
juice (ALPEX Co., Łe˛czeszyce, Poland), as described by 
Jus´kiewicz et al. [16]. Briefly, the fresh pomace was dried 
in an industrial vacuum dryer at 70 ± 2 °C and then passed 
through sieves. The seedless fraction was subjected to a 
two-stage extraction with a 60 % aqueous solution of ace-
tone. Next, after partial removal of the solvent via distilla-
tion, the resultant solutions were transferred onto a column 
packed with polymeric resin (Amberlite XAD 16, Sigma-
Aldrich). The sugars and other water-soluble compounds 
present in the solutions were eluted from the column with 
water. Then, monomeric and dimeric ET-rich fractions 
were desorbed with 10 and 40 % aqueous solution of eth-
anol, respectively, concentrated to ca. 15 % of dry matter 
and lyophilized. The methods used to determine the com-
position of the monomeric ET- and dimeric ET-rich extracts 
(details in Table 1) are described below.
The basic chemical composition of the extracts was 
determined according to the official methods of AOAC [17] 
Table 1  Chemical composition 
of strawberry ET extracts
The results are expressed as the mean ± SD, n = 2
ETs ellagitannins
a Low molecular carbohydrates and structural components of plant cell walls, including dietary fibre
Monomeric ET-rich extract (g/100 g) Dimeric ET-rich extract (g/100 g)
Dry matter 94.31 ± 0.25 91.31 ± 0.05
Ash 0.34 ± 0.02 0.03 ± 0.04
Fat – –
Protein 5.62 ± 0.05 1.83 ± 0.03
Other componentsa 0.35 ± 0.01 7.17 ± 0.01
Total polyphenols 88.0 ± 0.1 82.3 ± 0.1
 Ellagic acid 0.1 ± 0.0 0.2 ± 0.0
 ETs 80.0 ± 0.1 57.3 ± 0.1
  Monomers 77.1 ± 0.1 23.3 ± 0.1
  Dimers 2.9 ± 0.0 34.0 ± 0.1
 Proanthocyanidins 8.1 ± 0.3 23.9 ± 0.2
 Flavonols – 0.9 ± 0.0
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using the following procedures: 940.26 (dry substance and 
ash), 920.152 (protein), 930.09 (raw fat) and 985.29 (total 
dietary fibre).
The concentrations of ETs, ellagic acid, anthocyanins 
and flavonols were determined in the extracts after their 
dilution in methanol (1 mg/mL) using HPLC (Knauer 
Smartline system with photodiode array detector, Berlin, 
Germany) coupled with a Gemini C18 column (110 Å, 
250 × 4.60 mm; 5 μm, Phenomenex, Torrance, USA). 
Phase A was 0.05 % phosphoric acid in water, phase B was 
0.05 % phosphoric acid in 80 % acetonitrile, the flow rate 
was 1.25 mL/min, the sample volume was 20 μL, and the 
temperature was 35 °C. Gradient: stabilization for 5 min 
with 4 % of phase B, 4–15 % B for 5–12.5 min, 15–40 % B 
for 12.5–42.5 min, 40–50 % B for 42.5–51.8 min, 50–55 % 
B for 51.8–53.4 min and 4 % B for 53.4–55 min. The fol-
lowing standards were used for the identification of the 
polyphenols: ellagic acid, flavonols (quercetin-3-O-glu-
coside, kaempferol-3-O-glucoside, quercetin, kaempferol, 
tiliroside), pelargonidin-3-O-glucoside (all from Extrasyn-
these, Genay, France), p-coumaric acid (Sigma-Aldrich) 
and samples of ETs, specifically hexahydroxydiphenoyl-
d-glucose and agrimoniin, obtained by semipreparative 
HPLC as described by Sójka et al. [12]. The absorbance 
was measured at 280 nm (p-coumaric acid, tiliroside, hex-
ahydroxydiphenoyl-d-glucose and agrimoniin), 360 nm 
(ellagic acid, quercetin, kaempferol and kaempferol glyco-
sides) and 520 nm (anthocyanins).
The concentration of proanthocyanidins in the extracts 
was determined by the HPLC method after proanthocya-
nidin breakdown in an acidic environment with an excess of 
phloroglucinol, according to Kennedy and Jones [18]. The 
obtained breakdown products were separated using Knauer 
Smartline chromatograph (Berlin, Germany) equipped with 
an UV–Vis detector (PDA 280, Knauer, Berlin, Germany) 
and a fluorescence detector (Shimadzu RF-10Axl, Kyoto, 
Japan) and coupled with a Gemini C18 column (110 Å, 
250 × 4.60 mm; 5 μm, Phenomenex, Torrance, USA). The 
separation conditions were described by Kosmala et al. [8]. 
The identification was performed at 280 nm using a UV–
Vis detector and the following standards: (−)-epicatechin, 
(+)-catechin, (−)-epigallocatechin and their respective 
phloroglucinol adducts. Quantification was conducted by 
peak areas registered by a fluorescence detector (excitation 
wavelength 278 nm; emission wavelength 360 nm). Stand-
ard curves of (−)-epicatechin and (+)-catechin for terminal 
units and (−)-epicatechin-phloroglucinol adduct for extender 
units were used to quantify the breakdown products.
Feeding experiment
The experiment was conducted on 48 male Wistar rats 
weighing 257 ± 0.858 g, randomly assigned to one of six 
groups of eight rats each. The animals were maintained 
individually in metabolic cages under a stable temperature 
(21–22 °C), a 12-h light:12-h dark cycle and a ventilation 
rate of 15 air changes per hour. The rats were used in com-
pliance with the European guidelines for the care and use of 
laboratory animals, and the animal protocol was approved 
by the Local Institutional Animal Care and Use Committee 
(permission no. 32/2012; Olsztyn, Poland). For 4 weeks, 
the rats had free access to tap water and semipurified diets, 
which were prepared and then stored at 4 °C in hermetic 
containers until the end of the experiment. The diets were 
modifications of a casein diet for laboratory rodents recom-
mended by the American Institute of Nutrition [19] (details 
in Table 2). Two groups of rats were fed with a control diet 
containing either cellulose (CEL; 6 % of the diet) or CEL 
and FOS (3 % of the diet each) as dietary fibre sources 
(groups C or C + FOS, respectively). Raftilose P95 with 
a degree of polymerization 2-7 (Beneo-Orafti, Oreye, Bel-
gium) was used in the diets as the FOS source. The other 
four groups were fed with the above-mentioned diets 
but also contained either the monomeric ET-rich extract 
(0.23 % of the diets, groups ME and ME + FOS) or the 
dimeric ET-rich extract (0.24 % of the diets, groups DE and 
DE + FOS), which were both added at the expense of corn 
starch. All experimental diets had a similar content of poly-
phenols; however, they differed in terms of the content of 
monomeric and dimeric ETs and proanthocyanidins. The 
diets fed to the ME and ME + FOS groups had a higher 
total ET content with a monomer-to-dimer ratio of 96 to 4. 
The diets fed to the DE and DE + FOS group had a lower 
total ET content with a monomer-to-dimer ratio of 40 to 60.
Sample collection and basic analyses
At the termination of the experiment, the rats were weighed 
and anesthetized with sodium pentobarbital (50 mg/kg 
body weight). After a laparotomy, blood samples were col-
lected from the caudal vein and stored in tubes containing 
heparin, and the intestinal segments (small intestine, cae-
cum and colon) and internal organs (heart, kidneys and 
liver) were removed and weighed. The blood was then cen-
trifuged for 15 min at 380×g, and the obtained plasma was 
stored at −20 °C until analyses.
Samples of the ileal, caecal and colonic digesta were 
collected, and the pH was immediately measured using a 
microelectrode and a pH/ION meter (model 301; Hanna 
Instruments, Vila do Conde, Portugal). In the fresh caecal 
digesta, the dry matter was determined at 105 °C, whereas 
the ammonia concentration was determined by the micro-
diffusion method in Conway’s dishes. After storage of the 
caecal digesta at −70 °C, the short-chain fatty acid (SCFA) 
concentrations were measured using gas chromatography 
(Shimadzu GC-2010, Kyoto, Japan) and a capillary column 
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(SGE BP21, 30 m × 0.53 mm; SGE Europe Ltd., Milton 
Keynes, UK) as previously described [8].
In the blood plasma, the antioxidant capacity of water-
soluble and lipid-soluble substances (ACW and ACL, 
respectively) was determined by a photochemilumines-
cence detection method using a Photochem and respective 
kits (ACW-Kit and ACL-Kit, Analytik Jena AG, Germany). 
In the photochemiluminescence assay, the generation of 
free radicals was partially eliminated through reactions 
with antioxidants present in the plasma samples, and the 
remaining radicals were quantified by luminescence gen-
eration. Ascorbate and Trolox calibration curves were used 
to evaluate ACW and ACL, respectively.
Thiobarbituric acid-reactive substances (TBARS) were 
determined in the heart, kidney and liver tissue after their 
storage at −70 °C. A procedure developed by Botsoglou 
et al. [20] was used in the assay, and the TBARS contents 
were determined spectrophotometrically at 532 nm and 
expressed in µg malondialdehyde per g of tissue.
Determining bacterial counts
The caecal digesta was weighed and subjected to a bacte-
rial DNA isolation procedure using a bead-beating method 
according to the protocol of the GeneMATRIX Stool DNA 
Purification Kit (Eurx, Gdan´sk, Poland). Quantitative real-
time polymerase chain reaction (PCR) was run in duplicate. 
The reactions were conducted in an iQ5 real-time PCR 
system (Bio-Rad, Warsaw, Poland) in a total volume of 
25 µL consisting of 12.5 µL of SYBR® Green JumpStart™ 
Taq ReadyMix™ (Sigma-Aldrich), 200 µM of each respec-
tive primer, 1 µL of tenfold diluted DNA and PCR-grade 
water (Sigma-Aldrich). The amplification was based on an 
initial denaturation at 95 °C for 3 min, followed by 35 cycles 
of denaturation at 95 °C for 20 s, annealing at a primer-spe-
cific temperature for 30 s and a final cycle at 72 °C for 30 s. 
Primer sequences and annealing temperatures are available 
upon request. After completion of the amplifications, a melt-
ing curve was prepared to confirm the specificity of PCR 
products. The construction of the standard curve for each 
real-time PCR analysis was based on bacterial strains from 
our own culture collection and from the German Collection 
of Microorganisms and Cell Cultures. Each bacterial culture 
was separately cultivated in appropriate conditions (details 
available upon request), and the cell count was determined 
using 4′,6-diamidino-phenylindole (Sigma-Aldrich) with a 
procedure described elsewhere [21]. Two millilitres of each 
culture was centrifuged (5 min, 10,000×g), washed with 
sterile PBS (pH 7.4) and then centrifuged again. The cell 
pellets were combined and mixed with 0.1 g of the auto-
claved caecal digesta, and bacterial DNA was isolated with 
the above-mentioned method. Isolated DNA was serially 
diluted and used for the construction of the standard curve 
for each primer pair tested. The data were analysed using 
iQ5 Optical System Software (version 2.0) and expressed as 
the cell count per g of the caecal digesta.
Table 2  Composition of the group-specific diets
ET ellagitannins
a Raftilose P95 with a degree of polymerization 2-7 (Beneo-Orafti, Oreye, Belgium)
b Chemical composition in Table 1
c Recommended for the AIN-93 M diet [19]
Group (%)
C C + FOS ME ME + FOS DE DE + FOS
Casein 14.8 14.8 14.8 14.8 14.8 14.8
DL-methionine 0.2 0.2 0.2 0.2 0.2 0.2
Rapeseed oil 8 8 8 8 8 8
Cellulose 6 3 6 3 6 3
Fructo-oligosaccharidesa – 3 – 3 – 3
Corn starch 66.3 66.3 66.07 66.07 66.06 66.06
Monomeric ET-rich extract2 – – 0.23 0.23 – –
Dimeric ET-rich extractb – – – – 0.24 0.24
Vitamin mixc 1 1 1 1 1 1
Mineral mixc 3.5 3.5 3.5 3.5 3.5 3.5
Choline chloride 0.2 0.2 0.2 0.2 0.2 0.2
Calculated dietary contents
 Total polyphenols – – 0.203 0.203 0.197 0.197
 Ellagitannins (monomer:dimer ratio) – – 0.184 (96:4) 0.184 (96:4) 0.138 (40:60) 0.138 (40:60)
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Quantification of ellagic acid and ET metabolites
Ellagic acid concentration was determined in the caecal 
digesta after their hydrolysis with trifluoroacetic acid. The 
digesta (0.2 mg) was mixed with 70 % glycerol (0.5 mL) 
and 75 µL of trifluoroacetic acid and incubated at 95 °C 
for 18 h. Afterwards, the sample was cooled and extracted 
3 times using 1.5 mL of methanol in an ultrasonic bath. 
After each extraction, the sample was centrifuged (3 min, 
10,000×g), and the supernatant was collected in a volu-
metric flask and filled up with methanol. Ellagic acid was 
then determined using HPLC (Knauer Smartline system 
with photodiode array detector, Berlin, Germany) coupled 
with a Gemini C18 column (110 Å, 250 × 4.60 mm; 5 μm, 
Phenomenex, Torrance, USA). Phase A was 0.05 % phos-
phoric acid in water, phase B was 0.05 % phosphoric acid 
in 80 % acetonitrile, the flow rate was 1.25 mL/min, the 
sample volume was 20 μL, and the temperature was 35 °C. 
The gradient was as follows: 10–25 % B for 0–10 min, 
25–40 % B for 10–20 min, 40–80 % B for 20–25 min, 
80 % B for 25–30 min, 80–10 % B for 30–32 min, 10 % B 
for 32–40 min. The identification and quantification were 
performed at 360 nm with ellagic acid as a standard.
The concentration of ET metabolites was determined 
in the caecal digesta and plasma. A frozen sample of the 
digesta (0.5–1 g) was mixed with acetone (2 mL), sonicated 
for 10 min and centrifuged (5 min, 10,000×g), and then, 
the supernatant was collected in a test tube. The procedure 
was repeated twice with 2 and 1 mL of 70 % acetone. After 
collection of the supernatant, the extract was concentrated 
using a vacuum concentrator (ScanSpeed 40, Labogene, 
Denmark) and then dissolved in methanol (1 mL). ET 
metabolites were then determined using HPLC (Knauer 
Smartline system with photodiode array detector, Berlin, 
Germany) coupled with a Gemini C18 column (110 Å, 
250 × 4.60 mm; 5 μm, Phenomenex, Torrance, USA). Sep-
aration conditions were the same as those used in the deter-
mination of ETs in dietary extracts. ET metabolites were 
identified by comparison of UV spectra with the available 
literature data [22] and additionally confirmed by a MS/
MS method described below. A plasma sample (0.5 mL) 
was mixed with acetone (1 mL), sonicated for 10 min and 
centrifuged (5 min, 10,000×g), and then, the supernatant 
was collected in a test tube. The procedure was repeated, 
and both supernatants were collected in a test tube and 
concentrated using a vacuum concentrator (ScanSpeed 40, 
Labogene, Denmark). Next, the concentrated sample was 
dissolved in methanol (200 µL) and analysed by HPLC–
ESI–MS using a Dionex UltiMate 3000 UHPLC and a 
Thermo Scientific Q Exactive series quadrupole ion trap 
mass spectrometer. ET metabolites were separated using a 
Kinetex C18 column (110 Å, 150 × 2.1 mm; 2.6 μm, Phe-
nomenex, Torrance, USA) and a binary gradient of 0.1 % 
formic acid in water (phase A) and 0.1 % formic acid in 
acetonitrile (phase B) at a flow rate of 0.5 mL/min, as fol-
lows: stabilization for 1.44 min with 5 % B, 5–15 % B for 
1.44–2.98 min, 15–40 % B for 2.98–10.1 min, 40–73 % B 
for 10.1–11.5 min, 73 % B for 11.55–12.7 min, 73–5 % 
B for 12.7–13.28 min, 5 % B for 13.28–18 min. The MS 
analysis was performed in negative ion mode under the fol-
lowing conditions: capillary voltage at +4 kV, sheath gas 
pressure at 75 arbitrary units, auxiliary gas at 17 arbitrary 
units and scan range 120–1200 m/z. Urolithin-A isolated 
from human urine by semipreparative HPLC was used as 
a standard for the quantification of ET metabolites. The 
detailed procedure of urolithin-A isolation is described 
elsewhere [15].
Statistical analysis
The results are expressed as the mean ± SEM except for 
the chemical composition of the strawberry extracts, which 
is expressed as the mean ± SD. A 2-factor analysis of vari-
ance (ANOVA) was used to determine the effect of the 
extract additions (none, monomeric ET- or dimeric ET-rich 
extract) and the FOS addition and the interaction between 
these two factors (Extract × FOS). If the analysis revealed 
a significant interaction or both effects or the extract addi-
tions had a significant effect (P ≤ 0.05), the differences 
among the respective treatment groups were then deter-
mined with Duncan’s post hoc test at P ≤ 0.05. If ANOVA 
assumptions were violated, the Kruskal–Wallis one-way 
ANOVA by ranks was used followed by Dunn’s post hoc 
test (P ≤ 0.05). The statistical analysis was performed 
using STATISTICA software, version 10.0 (StatSoft Corp., 
Kraków, Poland).
Results
After 4 weeks of experimental feeding, the diet intake 
and body weight gain did not differ among the groups 
(data not shown, P > 0.05). The mass of the small intes-
tine with contents relative to body weight was increased 
by the FOS addition (P < 0.005), whereas the pH value 
of the ileal digesta was decreased (P < 0.001, Table 3). 
Moreover, the caecal tissue mass relative to body weight 
and the caecal digesta mass relative to the tissue mass 
were increased by dietary FOS (P < 0.001 and P < 0.01, 
respectively), whereas the pH value and the ammonia con-
centration in the caecal digesta were decreased (P < 0.001 
and P < 0.005, respectively; Table 3). An interaction 
effect between the extract and the FOS addition was also 
observed in examining the caecal tissue mass (P = 0.05); 
however, no additional relationships in Duncan’s post hoc 
test were noted. The dry matter of the caecal digesta was 
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affected by the extract addition (P < 0.01), and an inter-
action between this dietary factor and the FOS addition 
was also noted (P < 0.05). Thus, the digesta dry matter 
was higher in the ME + FOS and DE group than in the 
C, C + FOS and DE + FOS groups (P ≤ 0.05). Moreo-
ver, the acetate and total SCFA concentrations in the cae-
cal digesta were affected both by the extract and FOS addi-
tion (P < 0.05 and P < 0.001, respectively) as well as their 
interaction (P < 0.05). The caecal acetate and total SCFA 
concentrations were higher in the FOS groups than in the 
C, ME and DE groups, except for the DE + FOS group 
in which the concentrations were the same as those in the 
later groups (P ≤ 0.05). The caecal propionate concentra-
tion was affected by the extract addition (P < 0.001), and 
its level was lower in the ME + FOS and DE + FOS group 
than in the C + FOS group (P ≤ 0.05). The caecal butyrate 
concentration was increased by dietary FOS (P < 0.005). 
Moreover, the extract and FOS addition decreased the con-
centration of putrefactive SCFAs (P < 0.05 and P < 0.001, 
respectively) calculated as the sum of isobutyrate, isovaler-
ate and valerate in the caecal digesta. The lowest concen-
tration of putrefactive SCFAs was in the ME + FOS group, 
and the concentrations were significantly higher in the 
C + FOS and DE + FOS groups. The highest concentra-
tion of SCFAs was in the C group (P ≤ 0.05).
The total and selected bacterial counts in the caecal 
digesta are shown in Table 4. The extract addition, the FOS 
addition and their interaction significantly affected the total 
bacterial count (all P < 0.001), which was the highest in 
the C + FOS group, significantly lower in the DE group 
and the lowest in the ME + FOS group (all P ≤ 0.05). The 
count of Atopobium genus was affected by the extract addi-
tion (P < 0.001), and an interaction between both dietary 
factors was noted (P < 0.005). The lowest Atopobium 
counts were in the ME + FOS group, and they were sig-
nificantly increased in the ME group (P ≤ 0.05) but not to 
the highest level observed in the C + FOS and DE + FOS 
groups (P ≤ 0.05). The count of Bifidobacterium genus was 
affected by the extract addition and by dietary FOS (both 
P < 0.001) as well as their interaction (P < 0.005). The Bifi-
dobacterium counts were the highest in the C + FOS group 
and the lowest in both ME groups. In the DE group, the 
Bifidobacterium counts were also relatively low; however, 
the FOS addition increased them significantly (P ≤ 0.05), 
which was not observed in the ME groups. Furthermore, 
the count of Enterococcus genus was affected by both die-
tary factors at P < 0.001. The lowest Enterococcus counts 
were noted in the ME + FOS group, and they were signifi-
cantly higher in the DE + FOS group, whereas the high-
est values were noted in the C group (all P ≤ 0.05). The 
count of Lactobacillus genus was increased by the FOS 
addition (P < 0.001), but the extract addition also had a 
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counts did not differ between the ME + FOS group and the 
ME group, whereas they were increased in the C and DE 
group compared to those of the C + FOS and DE + FOS 
group, respectively. Moreover, the count of Bacteroides-
Prevotella-Porphyromonas was affected by both tested fac-
tors and their interaction (all P < 0.001), and thus, it was 
lower in the ME + FOS group than in the other groups 
(P ≤ 0.05). The Clostridium leptum group was significantly 
affected by both tested factors and their interaction (all 
at P < 0.001), and its count was lower in the ME + FOS 
group than in the other groups (P ≤ 0.05).
The ellagic acid determined after hydrolysis of the 
caecal digesta was absent in both C groups, whereas in 
the other groups, it was present at various concentrations 
(P < 0.001). The ellagic acid concentration was lower in 
the DE group than in the ME + FOS and DE + FOS 
groups (P ≤ 0.05, Table 5). ET-specific metabolites were 
detected in the caecal digesta and blood plasma of the ME 
and DE groups, but they were not present at all in the C 
groups. The total concentration of ET metabolites in the 
caecal digesta was higher in the ME and ME + FOS groups 
than in the DE and DE + FOS groups. Nasutin-A was the 
main ET metabolite found in the caecal digesta, and its 
concentration was higher in the ME groups than in the DE 
groups (P ≤ 0.05). In the caecal digesta, a relatively low 
concentration of urolithin-A was also found, but only in the 
ME + FOS group. Additionally, isonasutin-A-glucuronide 
was present in the caecal digesta of all ME and DE groups, 
and its concentration was higher in the ME + FOS group 
than in the ME group (P ≤ 0.05). The total plasma con-
centration of ET metabolites was higher in the ME + FOS 
and DE + FOS groups than in the ME group. Urolithin-A 
was the main plasma metabolite found in the ME + FOS, 
DE and DE + FOS groups, whereas in the ME group, it 
was not present. The plasma urolithin-A concentration 
was higher in the DE + FOS group than in the DE group 
(P ≤ 0.05). Additionally, isonasutin-A-glucuronide and 
nasutin-A-glucuronide were identified in the blood plasma. 
The plasma isonasutin-A-glucuronide concentration was 
on a similar level in both DE groups and in the ME + FOS 
group, whereas in the ME group, it was not detected. The 
plasma nasutin-A-glucuronide concentration was the high-
est in the ME group and was slightly and significantly 
lower in the ME + FOS and DE groups, respectively 
(P > 0.05 and P ≤ 0.05, respectively). In the DE + FOS 
group, the metabolite was absent.
The plasma ACW concentration was affected by the 
extract addition (P < 0.001), and it was the highest in the 
ME + FOS group (P ≤ 0.05), slightly lower in the ME 
group (P > 0.05) and significantly lower in the other groups 
Table 5  Concentration of ellagic acid in hydrolysed caecal digesta and ET metabolites in the caecal digesta and plasma of rats fed diets contain-
ing monomeric ET- or dimeric ET-rich extract without or with FOS for 4 weeks
Values are mean ± SEM, n = 8. Means within a column without a common letter differ, P ≤ 0.05 (Dunn’s post hoc test). ETs ellagitannins, FOS 
fructo-oligosaccharides, ND not detected, NS non-significant data, P > 0.05
1 ME, fed a diet supplemented with a monomeric ET-rich extract; ME + FOS, fed a diet containing FOS and supplemented with a monomeric 
ET-rich extract; DE, fed a diet supplemented with a dimeric ET-rich extract; DE + FOS, fed a diet containing FOS and supplemented with a 
dimeric ET-rich extract
2 HPLC retention time (min) 10.08; MS [M–H]− 269; MS/MS fragments 113, 85.03; UV spectra (nm) 227, 245, 284, 323, 389
3 HPLC retention time (min) 8.08; MS [M–H]− 445; MS/MS fragments 269.01, 113, 85.03; UV spectra (nm) 218, 264, 332
4 HPLC retention time (min) 9.54; MS [M–H]− 227; MS/MS fragments 113.02, 85.03; UV spectra (nm) 197, 218, 280, 307, 355
5 HPLC retention time (min) 6.99; MS [M–H]− 445; MS/MS fragments 269.01, 113, 85.03; UV spectra (nm) 222, 279, 315, 367, 379
Group1 Kruskal–Wallis
ANOVA
P valueME ME + FOS DE DE + FOS
Caecal digesta
 Ellagic acid, mg/g 1.95ab ± 0.058 2.41a ± 0.016 1.61b ± 0.024 2.04a ± 0.065 <0.001
 Total metabolites, µg/g 67.8ab ± 10.7 89.5a ± 15.0 13.0c ± 0.98 18.0bc ± 3.33 <0.001
  Nasutin-A2, µg/g 62.7a ± 19.5 79.2a ± 15.3 6.28b ± 1.37 10.3b ± 3.82 <0.001
  Isonasutin-A-glucuronide3, µg/g 5.12b ± 0.363 9.19a ± 1.09 6.68ab ± 0.568 7.76ab ± 0.860 <0.05
  Urolithin-A4, µg/g ND 1.10 ± 0.384 ND ND –
Plasma
 Total metabolites, ng/mL 8.13b ± 2.12 248a ± 43.8 146ab ± 19.2 281a ± 47.5 <0.001
  Urolithin-A4, ng/mL ND 235ab ± 44.0 136b ± 19.1 271a ± 47.9 <0.01
  Isonasutin-A-glucuronide3, ng/mL ND 10.1 ± 1.25 10.1 ± 0.834 10.8 ± 1.50 NS
  Nasutin-A-glucuronide5, ng/mL 8.13a ± 2.12 2.65ab ± 1.75 0.283b ± 0.283 ND <0.005
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(P ≤ 0.05, Fig. 1). The TBARS contents in selected tis-
sues are depicted in Fig. 2. The liver TBARS contents were 
decreased by dietary FOS (P = 0.01), whereas the kidney 
TBARS contents were affected by the extract addition 
(P < 0.05). Compared to all C and ME groups, the kidney 
TBARS contents were slightly and significantly lower in 
the DE and DE + FOS groups, respectively (P > 0.05 and 
P ≤ 0.05, respectively).
Discussion
ETs and ellagic acid are present in high quantities in 
some fruits, such as pomegranates, blackberries, straw-
berries, raspberries and cloudberries, as well as in some 
nuts, such as almonds and walnuts [2, 9]. In strawberries, 
ETs together with unbounded ellagic acid are thought to 
be the second largest class of polyphenols after anthocya-
nins, whereas proanthocyanidins seem to be quantitatively 
less important [9]. However, a study of Buendía et al. [23] 
clearly showed that the content of proanthocyanidins can 
be even higher than ETs and anthocyanins. In strawberry 
pomace, both high contents of ETs and proanthocyanidins 
have been found, whereas anthocyanins were minor com-
ponents, which is most likely due to their easier transfer 
from the fruit to the juice during industrial pressing [12]. In 
this study, two components were extracted from strawberry 
pomace, which contained >82 % polyphenols with ETs as 
their predominant class (Table 1). The monomeric ET-rich 
extract had a higher total content of ETs than the dimeric 
ET-rich extract (80 vs. 57/100 g extract), whereas the latter 
had a higher content of proanthocyanidins (24 vs. 8/100 g 
extract) and contained significant amounts of monomeric 
ETs (23/100 g extract). All of the obtained differences were 
due to fractionation of the extracted polyphenols on a syn-
thetic resin.
FOS as a part of dietary fibre occur naturally in many 
plants, among which tubers of Jerusalem artichoke and 
chicory root are some of the most abundant sources. A 
typical intestinal change was observed in the present study 
following the FOS ingestion, such as acidification of the 
digesta and an increase in the digesta fresh weight and 
in total and individual SCFA concentrations, including 
butyrate concentration [14, 24]. The FOS supplementation 
also limited putrefaction in the caecum as displayed by the 
decreased ammonia and putrefactive SCFA concentrations. 
All of the aforementioned changes are considered benefi-
cial for the organism. For example, butyrate is recognized 
as a preferred substrate for colonocytes, and it appears to 
protect against colorectal cancer, whereas ammonia can 
induce cancerous cell growth [14, 25, 26]. In this study, the 
FOS supplementation also stimulated lactic acid bacteria 
and bifidobacteria growth, and these strains can exert pro-
biotic effects [27]. It is worth noting, however, that dietary 
extracts limited those beneficial changes to some extent, 
such as the production of SCFAs, and its total concentration 
did not increase when FOS was added to the diet together 
Fig. 1  Plasma ACW and ACL in rats fed diets containing monomeric 
ET- or dimeric ET-rich extract without or with FOS for 4 weeks. Val-
ues are mean ± SEM, n = 8. Means without a common letter dif-
fer, P ≤ 0.05 (Duncan’s post hoc test). ACL antioxidant capacity of 
lipid-soluble substances, ACW antioxidant capacity of water-soluble 
substances, CEL cellulose, ETs ellagitannins, FOS fructo-oligosac-
charides. C control fed a diet with CEL as a sole source of dietary 
fibre; C + FOS control fed a diet with FOS added at the expense of 
CEL; ME fed a diet supplemented with a monomeric ET-rich extract; 
ME + FOS fed a diet containing FOS and supplemented with a mon-
omeric ET-rich extract; DE fed a diet supplemented with a dimeric 
ET-rich extract; DE + FOS fed a diet containing FOS and supple-
mented with a dimeric ET-rich extract
Fig. 2  TBARS in the liver, heart and kidney of rats fed diets con-
taining monomeric ET- or dimeric ET-rich extract without or with 
FOS for 4 weeks. Values are mean ± SEM, n = 8. Means without 
a common letter differ, P ≤ 0.05 (Duncan’s post hoc test). CEL cel-
lulose, ETs ellagitannins, FOS fructo-oligosaccharides, NS non-
significant data, P > 0.05; TBARS thiobarbituric acid-reactive sub-
stances. C control fed a diet with CEL as a sole source of dietary 
fibre, C + FOS control fed a diet with FOS added at the expense of 
CEL, ME fed a diet supplemented with a monomeric ET-rich extract; 
ME + FOS fed a diet containing FOS and supplemented with a mon-
omeric ET-rich extract; DE fed a diet supplemented with a dimeric 
ET-rich extract; DE + FOS fed a diet containing FOS and supple-
mented with a dimeric ET-rich extract
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with the dimeric ET-rich extract. Moreover, the growth of 
bifidobacteria and lactic acid bacteria were inhibited by the 
monomeric ET-rich extract which confirms the antibacte-
rial activity of ETs established in vitro [2, 28]. It has been 
suggested that ETs can interact with bacterial enzymes and 
damage bacterial cell walls and membranes [28]. While 
the available literature data are consistent in terms of the 
inhibitory effect of ETs on pathogenic bacteria, their effect 
on probiotic bacteria is not fully recognized. Larrosa et al. 
[29] showed that the ingestion of ETs and their metabolites 
can increase Bifidobacterium and Lactobacillus counts in 
rat faeces, whereas in human subjects, Bialonska et al. [30] 
did not find such overall increases; however, the growth of 
some individual species was enhanced or even inhibited. 
Surprisingly, in this study, especially strong antibacterial 
activity was noted in the caecum of rats fed the monomeric 
ET-rich extract and FOS, in which both the total bacte-
rial population and a majority of individual populations 
were reduced by at least one order of magnitude (group 
ME + FOS vs. groups C and C + FOS, Table 4).
Generally, the mechanism of ET breakdown within the 
gastrointestinal tract is believed to depend on two main 
factors. First, the intestinal pH can directly hydrolyse ETs, 
and second, the microbiota can convert ETs and ellagic 
acid to more bio-available compounds, such as urolithins 
[2–5, 31, 32]. Importantly, two strains of the Gordonibac-
ter genus able to metabolize ellagic acid to urolithins have 
been recently identified in human faeces [33]. In this case, 
however, the ET metabolism may be a bacterial defence 
mechanism against the antibacterial activity of ETs. A lack 
of trihydroxybenzoyl groups in most ET metabolites con-
firms this supposition because their presence in ET mol-
ecules seems to determine their antibacterial power [28]. 
Nevertheless, in this study, although up to 1.84 mg ETs 
were present in a gram of experimental diets, the total con-
centration of ET metabolites in the caecum did not exceed 
90 µg per g digesta. Additionally, the experimental diets 
contained only traces of unbounded ellagic acid (≤4.8 µg/g 
diet), whereas their large quantities were released from ET 
molecules after hydrolysis of the caecal digesta (≥1.6 mg/g 
digesta). Because the caecum is the main site of intestinal 
fermentation in rats, the obtained results indicate a very 
limited breakdown of ETs. This finding is in agreement 
with Aguilera-Carbo et al. [1] who emphasized difficulties 
in the biodegradation of ETs. Considering all of the afore-
mentioned, we suggest that the initial release of ellagic 
acid induced by intestinal pH may be the rate-limiting step 
in the bacterial metabolism of ETs. Furthermore, in this 
study, the total concentration of ET metabolites in the cae-
cal digesta was approximately five times higher in the ME 
and ME + FOS groups than in the respective DE groups. 
Additionally, nasutin-A was the main caecal metabolite in 
the ME groups, in which its presence was more than six 
times greater than that in the DE groups. This result sug-
gests that monomeric ETs are more prone to the intestinal 
breakdown than dimeric ETs. However, the magnitude of 
the difference is not as large because the diets fed to the 
ME groups contained 25 % more ETs than those fed to the 
DE groups. Nevertheless, this evidence is in agreement 
with the findings of our previous study, in which a less 
polymerized structure of strawberry ETs than that of rasp-
berry ETs resulted in a higher caecal concentration of their 
metabolites [8]. Furthermore, the occurrence of nasutins in 
animal kingdom has already been reported by Moore [34] 
in the early 1960s. The present study and our previous stud-
ies [8, 15] suggest that nasutin-A is the predominant cae-
cal metabolite of strawberry ETs in rats. However, this 
finding seems to contradict the other available reports, in 
which urolithins were found as the only bacterial metabo-
lites of ETs both in rats and humans [3–5, 32]. We suggest 
two main reasons that can be responsible for this disagree-
ment. First are structural differences between strawberry 
ETs and pomegranate ETs, which were mainly tested in 
other studies, and may significantly affect microbial metab-
olism. Second is the analysis of caecal digesta instead of 
faeces, as it took place in other animal experiments as well 
as in human studies; thus, the time for interaction between 
strawberry ETs and the gut microbiota was much shorter.
In the present study, the absorption of ET metabolites 
into the bloodstream was also very limited, and although 
their micrograms were present in a gram of the caecal 
digesta, the total plasma concentration of ET metabolites 
did not exceed 300 ng/mL. Moreover, urolithin-A was the 
predominant plasma metabolite in most groups, and only 
small amounts of nasutin glucuronide derivatives were 
determined. This finding suggests that nasutin-A found as 
the main metabolite in the caecal digesta was barely, but to 
some extent, absorbed and might have been further metab-
olized and absorbed in the colon. This situation might have 
taken place especially in the DE groups, in which the total 
plasma concentration of ET metabolites was as high as in 
the respective ME groups. Surprisingly, urolithin-A was 
not present at all in the plasma of the ME group, and only 
traces of nasutin-A-glucuronide were determined there. 
Perhaps colonic bacteria were somehow able to transform 
monomeric ETs to much more simple compounds, such as 
phenolic acids and phloroglucinol, which are recognized 
to be the main polyphenol metabolites of gut microbiota 
[35]. However, the observed strong antibacterial activ-
ity of the monomeric ET-rich extract and FOS was prob-
ably enough to slow the bacterial breakdown, so we could 
determine more ET metabolites both in the caecal digesta 
and plasma of the ME + FOS group compared to the ME 
group. Moreover, the plasma urolithin-A was found in only 
an unconjugated form, whereas both the plasma nasutin-A 
and insonasutin-A were glucuronidated to increase their 
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water solubility and to facilitate their excretion, as is the 
case for many other polyphenols [36].
Oxidative stress can cause cell damage and underlies 
various chronic diseases and ageing; thus, dietary antioxi-
dants and their bio-availability are of interest [37]. ETs have 
high in vitro antioxidant activity; however, the results of 
in vivo studies are equivocal. An early study by Cerdá et al. 
[4] indicated that urolithins found in the plasma and urine 
of volunteers drinking pomegranate juice did not exert sig-
nificant antioxidant activity. However, a more recent study 
by Hassimotto and Lajolo [38] showed that although black-
berry ETs gavaged to rats did not increase the plasma anti-
oxidant capacity, they were able to reduce lipid peroxida-
tion determined by TBARS assay in select tissues (kidney, 
liver and brain). Another study on rats with gastric ulcers 
showed that an ellagitannin-rich fraction from Eucalyptus 
citriodora exerted dose-dependent antioxidant effects on 
the stomach tissue [39]. In this study, both dietary extracts 
beneficially affected the antioxidant status of rats if they 
were supplemented together with FOS, which is, to some 
extent, consistent with the FOS-induced increase in plasma 
ET metabolites. The monomeric ET-rich extract increased 
the plasma ACW concentration, whereas the dimeric ET-
rich extract decreased the content of TBARS in kidney tis-
sue. The reasons for these differences are not clear; how-
ever, the antioxidant balance of an organism depends on 
many interdependent antioxidants, such as glutathione, uric 
acid, antioxidant vitamins and enzymes [37].
In conclusion, although ETs of the monomeric ET-rich 
extract are more prone to the intestinal breakdown than 
those of the dimeric ET-rich extract, the overall bacte-
rial metabolism of strawberry ETs and absorption of their 
metabolites into the bloodstream is very limited. Moreover, 
we suggest that the initial release of ellagic acid induced by 
intestinal pH may be the rate-limiting step in the bacterial 
metabolism of ETs. A simultaneous inclusion of the mon-
omeric ET-rich extract and FOS in the diet evokes strong 
antibacterial activity in the caecum of rats, and it increases 
the intestinal absorption of ET metabolites due to their 
reduced intestinal breakdown. Strawberry ET-rich extracts 
can moderately improve the antioxidant status of rats by 
increasing the plasma ACW level if the monomeric ET-rich 
extract is included in the diet or by decreasing lipid peroxi-
dation in the kidney if the dimeric ET-rich extract and FOS 
are included in the diet.
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